Linesight provided Project Cost Control services for WuXi Biologics new state-of-the-art biopharmaceutical manufacturing campus in Dundalk, Ireland.
The manufacturing facility is one of the world’s largest facilities using single-use bioreactor technology for commercial biomanufacturing, as well as next-generation processing technology.
The design of the facility reflects best-in-class industry practice and represents a step change towards the ‘Factory of the Future’ concept. The development uses innovative technology optimised for the flexible production of multiple biologic drugs for multiple customers, using single-use disposable reactors, scale-up and scale-out systems and perfusion technology.
The Linesight Project Cost Control team provided an all embracing, single point of contact for all cost related services for this project.
The Project comprises a main Manufacturing building, a Laboratory and Admin building, Warehouse, Central Utilities Building (CUB), along with associated ancillary buildings (Substation, WWTP etc.).
Data
size
status
Michael McCabe
Director
Europe
Relevant Projects
Latest Insights
29th April 2024
Exploring emerging trends in sustainable construction cost management practices
Conrad Gorny, Associate Director, and Danielle Hurley, ESG Program Lead, shed light on some of key trends shaping sustainable construction cost management practices.
Continue Reading21 March 2024
Construction Market Insights - Europe
21 March 2024
Construction Market Insights - Americas